SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

NCT01266148 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Function and Chronic Allograft Vasculopathy

Interventions

DRUG: Cyclosporine
DRUG: Mycophenolate mofetil
DRUG: Corticosteroids
DRUG: Everolimus
DRUG: Anti Thymocyte Globulin

Sponsor

Novartis Pharmaceuticals